Brief: Enochian BioSciences Announces Findings From A Rigorous Internal Review Of Scientific Data

Lunai Bioworks

01/07/2022 22:22

July 1 (Reuters) - Enochian Biosciences Inc  ENOB.O :
    * ENOCHIAN BIOSCIENCES ANNOUNCES FINDINGS FROM A RIGOROUS
INTERNAL
REVIEW OF SCIENTIFIC DATA
    * ENOCHIAN BIOSCIENCES INC- RESULTS OF THIS INVESTIGATION
VERIFIED
KEY PRIMARY DATA FOR COMPANY'S HIV AND CANCER PIPELINES
    * ENOCHIAN BIOSCIENCES INC - WILL INITIATE LEGAL ACTION
AGAINST
GUMRUKÇU OVER FALSIFIED DATA
    * ENOCHIAN BIOSCIENCES - EVALUATING ITS INTERNAL CONTROLS
REGARDING REVIEW AND VERIFICATION OF EXTERNAL SCIENTIFIC DATA
AND WILL MODIFY AS APPROPRIATE
    * ENOCHIAN BIOSCIENCES - INVESTIGATION ALSO VERIFIED PRIMARY
DATA
FROM AN ANIMAL MODEL WITH INTRAVENOUS DELIVERY OF A POTENTIAL
TREATMENT FOR COVID-19
    * ENOCHIAN BIOSCIENCES - DISCOVERED FORMER SCIENTIFIC
ADVISOR
SERHAT GUMRUKÇU ALTERED 2 DIFFERENT SETS OF ANIMAL DATA
GENERATED BY THIRD-PARTY RESEARCH
    * ENOCHIAN-DISCOVERED FORMER SCIENTIFIC ADVISOR ALTERED 2
DIFFERENT SETS OF ANIMAL DATA GENERATED BY 3RD-PARTY RESEARCH
INSTITUTIONS BEFORE CO'S REVIEW
    * ENOCHIAN BIOSCIENCES -  GUMRUKÇU ALTERED ONE DATA SET WAS
FOR AN
INHALED COVID-19 TREATMENT STUDY WHILE OTHER WAS FOR AN HBV
THERAPY STUDY

Source text for Eikon:  ID:nGNXbH2XHL 
Further company coverage:  ENOB.O 

 ((Reuters.Briefs@thomsonreuters.com;))